These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 31769114

  • 1. Role of electrolyte concentrations and renin-angiotensin-aldosterone activation in the staging of canine heart disease.
    Adin D, Kurtz K, Atkins C, Papich MG, Vaden S.
    J Vet Intern Med; 2020 Jan; 34(1):53-64. PubMed ID: 31769114
    [Abstract] [Full Text] [Related]

  • 2. Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease.
    Ames MK, Atkins CE, Eriksson A, Hess AM.
    J Vet Cardiol; 2017 Jun; 19(3):218-227. PubMed ID: 28576479
    [Abstract] [Full Text] [Related]

  • 3. Effect of spironolactone and benazepril on furosemide-induced diuresis and renin-angiotensin-aldosterone system activation in normal dogs.
    Adin D, Atkins C, Wallace G, Klein A.
    J Vet Intern Med; 2021 May; 35(3):1245-1254. PubMed ID: 33713485
    [Abstract] [Full Text] [Related]

  • 4. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
    Häggström J, Hansson K, Karlberg BE, Kvart C, Madej A, Olsson K.
    Am J Vet Res; 1996 Nov; 57(11):1645-52. PubMed ID: 8915446
    [Abstract] [Full Text] [Related]

  • 5. The classical and alternative circulating renin-angiotensin system in normal dogs and dogs with stage B1 and B2 myxomatous mitral valve disease.
    Hammond HH, Ames MK, Domenig O, Scansen BA, Yang NT, Wilson MD, Sunshine E, Brunk K, Masters A.
    J Vet Intern Med; 2023 Nov; 37(3):875-886. PubMed ID: 36951394
    [Abstract] [Full Text] [Related]

  • 6. Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST).
    Coffman M, Guillot E, Blondel T, Garelli-Paar C, Feng S, Heartsill S, Atkins CE.
    J Vet Intern Med; 2021 Jul; 35(4):1673-1687. PubMed ID: 34028078
    [Abstract] [Full Text] [Related]

  • 7. Factors affecting the urinary aldosterone-to-creatinine ratio in healthy dogs and dogs with naturally occurring myxomatous mitral valve disease.
    Galizzi A, Bagardi M, Stranieri A, Zanaboni AM, Malchiodi D, Borromeo V, Brambilla PG, Locatelli C.
    BMC Vet Res; 2021 Jan 07; 17(1):15. PubMed ID: 33413406
    [Abstract] [Full Text] [Related]

  • 8. The effect of enalapril on furosemide-activated renin-angiotensin-aldosterone system in healthy dogs.
    Lantis AC, Ames MK, Werre S, Atkins CE.
    J Vet Pharmacol Ther; 2015 Oct 07; 38(5):513-7. PubMed ID: 25771846
    [Abstract] [Full Text] [Related]

  • 9. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
    Mentz RJ, Stevens SR, DeVore AD, Lala A, Vader JM, AbouEzzeddine OF, Khazanie P, Redfield MM, Stevenson LW, O'Connor CM, Goldsmith SR, Bart BA, Anstrom KJ, Hernandez AF, Braunwald E, Felker GM.
    JACC Heart Fail; 2015 Feb 07; 3(2):97-107. PubMed ID: 25543972
    [Abstract] [Full Text] [Related]

  • 10. Renin-angiotensin aldosterone profile before and after angiotensin-converting enzyme-inhibitor administration in dogs with angiotensin-converting enzyme gene polymorphism.
    Adin D, Atkins C, Domenig O, DeFrancesco T, Keene B, Tou S, Stern JA, Meurs KM.
    J Vet Intern Med; 2020 Mar 07; 34(2):600-606. PubMed ID: 32112596
    [Abstract] [Full Text] [Related]

  • 11. Clinical relevance of serum electrolytes in dogs and cats with acute heart failure: A retrospective study.
    Roche-Catholy M, Van Cappellen I, Locquet L, Broeckx BJG, Paepe D, Smets P.
    J Vet Intern Med; 2021 Jul 07; 35(4):1652-1662. PubMed ID: 34096660
    [Abstract] [Full Text] [Related]

  • 12. Effects of furosemide and the combination of furosemide and the labeled dosage of pimobendan on the circulating renin-angiotensin-aldosterone system in clinically normal dogs.
    Lantis AC, Atkins CE, DeFrancesco TC, Keene BW, Werre SR.
    Am J Vet Res; 2011 Dec 07; 72(12):1646-51. PubMed ID: 22126693
    [Abstract] [Full Text] [Related]

  • 13. Comparison between the effects of torsemide and furosemide on the renin-angiotensin-aldosterone system of normal dogs.
    Potter BM, Ames MK, Hess A, Poglitsch M.
    J Vet Cardiol; 2019 Dec 07; 26():51-62. PubMed ID: 31809955
    [Abstract] [Full Text] [Related]

  • 14. A prospective, randomized, double-blind, placebo-controlled pilot study of sacubitril/valsartan (Entresto) in dogs with cardiomegaly secondary to myxomatous mitral valve disease.
    Newhard DK, Jung S, Winter RL, Duran SH.
    J Vet Intern Med; 2018 Sep 07; 32(5):1555-1563. PubMed ID: 30084228
    [Abstract] [Full Text] [Related]

  • 15. Effect of furosemide and high-dosage pimobendan administration on the renin-angiotensin-aldosterone system in dogs.
    Ames MK, Atkins CE, Lantis AC, Werre SR.
    Am J Vet Res; 2013 Aug 07; 74(8):1084-90. PubMed ID: 23879846
    [Abstract] [Full Text] [Related]

  • 16. Aldosterone breakthrough with benazepril in furosemide-activated renin-angiotensin-aldosterone system in normal dogs.
    Lantis AC, Ames MK, Atkins CE, DeFrancesco TC, Keene BW, Werre SR.
    J Vet Pharmacol Ther; 2015 Feb 07; 38(1):65-73. PubMed ID: 25224804
    [Abstract] [Full Text] [Related]

  • 17. The effect of taurine supplementation on the renin-angiotensin-aldosterone system of dogs with congestive heart failure.
    Brethel S, Locker S, Girens R, Rivera P, Meurs K, Adin D.
    Sci Rep; 2023 Jul 03; 13(1):10700. PubMed ID: 37400490
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of subacute change in RAAS activity (as indicated by urinary aldosterone:creatinine, after pharmacologic provocation) and the response to ACE inhibition.
    Ames MK, Atkins CE, Lantis AC, zum Brunnen J.
    J Renin Angiotensin Aldosterone Syst; 2016 Jul 03; 17(1):1470320316633897. PubMed ID: 27009288
    [Abstract] [Full Text] [Related]

  • 19. Circulating renin-angiotensin-aldosterone system activity in cats with systemic hypertension or cardiomyopathy.
    Ward JL, Guillot E, Domenig O, Ware WA, Yuan L, Mochel JP.
    J Vet Intern Med; 2022 May 03; 36(3):897-909. PubMed ID: 35285549
    [Abstract] [Full Text] [Related]

  • 20. The renin-angiotensin-aldosterone system and its suppression.
    Ames MK, Atkins CE, Pitt B.
    J Vet Intern Med; 2019 Mar 03; 33(2):363-382. PubMed ID: 30806496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.